Medical risk-based approaches outperformed age-based strategies, even when vaccine prices were low, the study authors said.

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

Severe RSV can lead to serious outcomes. Elderly or immunocompromised patients in Singapore face an increased risk of cardiovascular complications such as heart failure and secondary pneumonia.

A surge in Respiratory Syncytial Virus (RSV) and fungal pneumonia cases is affecting children and senior citizens in Kolkata ...

For older adults, respiratory syncytial virus (RSV) vaccination is effective against RSV hospitalization, according to study findings.

After the COVID-19 pandemic subsided, children who were hospitalized for respiratory syncytial virus infections were older ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

Reformulated flu and COVID-19 shots are available to Oregonians starting this month. And an RSV vaccine — developed only last ...

A significant number of cases has been severe and patients are admitted in ICU at several facilities. Peerless Hospital has received 15 RSV patients in the last one month, which is slightly ...

ADMA stock surges 76.2% in three months on strong performance and high growth prospects. It recently hit its 52-week high ...

As RSV approaches, some "real world" data out of France provides even more support for the RSV antibody shot for babies.